After the market closed on 3/24/25, Adaptimmune (NASDAQ:ADAP) filed the company’s Form 10-K Annual Report. ADAP reported a net loss of $74.2 million for 4Q24, or $(0.05) per diluted ordinary ...

Adaptimmune Therapeutics PLC (ADAP) reports strong Tecelra launch, operational efficiencies, and strategic cost savings, while addressing future profitability and expansion plans. By Michael Kim ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Hello, and welcome to the Adaptimmune's Q4 and Full Year 2024 Business Update Conference Call. As a reminder, all participants are in a listen-only mode. The conference is being recorded. After ...

After hours: 26 March at 19:31:27 GMT-4 Loading Chart for ADAP ...

Shares of ADAP opened at $0.21 on Friday. The company has a quick ratio of 3.82, a current ratio of 3.85 and a debt-to-equity ratio of 0.62. Adaptimmune Therapeutics has a twelve month low of $0. ...

Apple has collaborated with Amazon to offer Apple TV+ through Prime Video in India, aiming to expand its user base amid growing competition. Indian Prime members can now subscribe to Apple TV+ for ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...